Enclomiphene and pregnancy: fertility facts men need to know

Last updated 2026-07-30

Can enclomiphene help you and your partner get pregnant?

Enclomiphene doesn't get pregnant anyone. It's not given to women and it has no approved role in female fertility treatment. The question people actually mean is narrower: does enclomiphene keep a man's sperm production intact while he's raising his testosterone, so that if he and a partner are trying to conceive, his fertility isn't the thing standing in the way? The honest answer is: probably better than testosterone therapy, but not proven to increase pregnancy rates on its own. Enclomiphene is a selective estrogen receptor modulator (SERM). It blocks estrogen receptors in the hypothalamus, which tells the brain there isn't enough estrogen around. The hypothalamus responds by pumping out more GnRH, which drives the pituitary to release more LH and FSH. Those two hormones are what actually run the testes: LH stimulates Leydig cells to make testosterone, FSH stimulates Sertoli cells to support sperm production ^[1]. That's the entire mechanism, and it's the reason enclomiphene gets discussed as a TRT alternative for men who still want to have kids. Exogenous testosterone shuts down that same LH/FSH signal through negative feedback. Enclomiphene amplifies it instead. Same goal (higher testosterone), opposite effect on the signal that keeps the testes working. No randomized trial has enclomiphene as the intervention and "partner became pregnant" as the endpoint. What exists are studies on testosterone levels, sperm parameters, and LH/FSH response. If you want the fertility angle covered in more depth alongside real user outcomes, the enclomiphene before and after page and the enclomiphene success rate breakdown both go further into what "working" looks like in practice.

How is enclomiphene different from TRT for a man trying to conceive?

TRT replaces testosterone from outside the body. The hypothalamus and pituitary sense that testosterone level and effectively stop asking the testes to make more. LH and FSH drop, intratesticular testosterone (which needs to be far higher locally than in the bloodstream to drive spermatogenesis) falls, and sperm counts often decline. Some men on TRT become azoospermic (zero sperm in the ejaculate) within months. Enclomiphene raises testosterone by stimulating the testes to produce it, not by adding testosterone from outside. LH and FSH go up rather than down. Testicular size, which shrinks on TRT because the testes stop being stimulated, tends to hold steady on enclomiphene because the stimulation continues ^[2]. Here's the comparison in plain terms: | Factor | Exogenous TRT | Enclomiphene |

Is enclomiphene FDA-approved, and does that affect pregnancy safety questions?

No. Enclomiphene citrate was developed under the brand name Androxal by Repros Therapeutics for secondary hypogonadism in men. It went through Phase 3 trials but the FDA program did not result in approval, and Repros discontinued the development effort. There is no FDA-approved enclomiphene product on the market today ^[3]. What's sold under names like "enclomiphene" is compounded medication, prepared by a compounding pharmacy under a prescription, not manufactured by a drug company that ran it through the FDA's standard approval pathway. Compounded drugs are regulated differently under FDA guidance for compounding (Sections 503A and 503B of the FD&C Act), and they are not FDA-approved in the way a drug like clomiphene citrate is ^[4]. That regulatory gap doesn't mean the underlying pharmacology is fake or fringe. Clomiphene citrate (Clomid, generic clomiphene) is FDA-approved, and it's actually a mixture of two isomers: enclomiphene and zuclomiphene. Enclomiphene is the trans-isomer and does most of the anti-estrogenic, gonadotropin-stimulating work. Zuclomiphene, the cis-isomer, has a much longer half-life, weaker estrogen-agonist activity, and is thought to contribute more of the side-effect profile without adding much benefit ^[5]. The theoretical appeal of isolated enclomiphene is getting the useful isomer without the one that lingers and does less for you. It's a plausible pharmacology argument, but it hasn't been proven out in an approved product, and the compounded formulations vary by pharmacy since there's no single FDA-set standard. If you're deciding whether the regulatory reality changes the calculus for you, the enclomiphene pros and cons piece and is enclomiphene worth it go through that tradeoff directly, including cost, monitoring burden, and what you're actually trusting when you fill the prescription.

What does the research actually show about enclomiphene and sperm count?

The strongest human data on enclomiphene come from a set of Phase 2/3 trials run for the Androxal program in the 2010s, plus smaller academic studies since. A 2013 randomized trial compared enclomiphene citrate to topical testosterone gel in hypogonadal men and found that enclomiphene raised total testosterone into the normal range while preserving sperm counts and LH/FSH levels, whereas the testosterone gel group saw sperm-relevant hormones (LH, FSH) suppressed ^[6]. A separate small study looking at hypogonadal men who wanted to preserve fertility found that enclomiphene increased testosterone, LH, and FSH without the drops in sperm parameters seen with exogenous testosterone, over relatively short follow-up windows (weeks to a few months) ^[2]. What's missing: large trials with sperm concentration or motility as a primary endpoint, tracked over the 3 month timeframe needed for a full spermatogenic cycle, and definitely no trial that tracked actual pregnancy rates in partners. Rat and clinical pharmacology data support the mechanism strongly. Long-term human reproductive-outcome data don't exist yet at the scale you'd want before calling this settled science. That's an honest gap, not a reason to dismiss the drug, but it's one marketing pages routinely skip over. If you want a sense of how quickly hormone changes show up when men start treatment (which is a separate question from sperm changes, which move slower), the enclomiphene results timeline covers what's tracked week to week versus what takes a full 3 months to assess.

Does enclomiphene affect testicular size the way TRT does?

Generally, no, and that's one of the more consistently reported findings. Testicular volume depends heavily on FSH-driven Sertoli cell activity and LH-driven Leydig cell activity, both of which enclomiphene increases rather than suppresses. TRT studies commonly report testicular volume reduction because the testes go relatively quiet when the brain sees plenty of testosterone already circulating. Men switching from TRT to enclomiphene, or comparing the two head to head, often report testicular size normalizing or being maintained on enclomiphene where it wasn't on testosterone therapy. This tracks with the mechanism (stimulation preserved vs. stimulation removed) and with the trial data on LH/FSH response ^{[2] [6]}, but there isn't a large study specifically measuring testicular volume as a primary outcome over years of enclomiphene use. Most of what exists comes from shorter trials and clinical observation.

How long before sperm parameters normalize on or off enclomiphene?

Spermatogenesis, start to finish, takes roughly 64 to 74 days in humans, plus another couple weeks for the sperm to transit the epididymis. That means any change to the hormonal environment, whether starting enclomiphene, stopping TRT, or anything else, takes a minimum of about 3 months to show up in a semen analysis, and often longer to fully stabilize ^[1]. This is the single most misunderstood timing issue in fertility-related hormone therapy. A man who checks a semen analysis 3 weeks after starting or stopping a medication is looking at sperm that were already mid-production before the change happened. If you or a partner are actively trying to conceive on a specific timeline, that 3-month lag needs to be part of the plan, not a surprise. Practically: if a man is coming off TRT specifically to restore fertility, enclomiphene (or clomiphene) is sometimes used as part of a recovery protocol precisely because it restimulates LH/FSH rather than waiting for spontaneous recovery, which can take many months to over a year in some men, especially after long-term or high-dose TRT use ^[7].

Is enclomiphene safer than TRT if a couple is trying to conceive?

"Safer" needs to be split into two different questions: safer for his fertility, and safer overall as a medication. For his fertility specifically, yes, the mechanism and the available trial data both point toward enclomiphene preserving sperm-relevant hormones where TRT suppresses them ^[6]. That's the core reason it gets recommended over TRT for men actively trying to have a child. Safer overall as a drug is a different, less settled question. Because enclomiphene isn't FDA-approved as a standalone product, there's no FDA-mandated long-term safety monitoring program, no standardized dosing across manufacturers, and no large post-market surveillance dataset the way there is for approved TRT products. Reported side effects in trials included visual disturbances (rare, more associated with clomiphene generally), mood changes, and the general side effects seen with SERMs, but the safety database is smaller than for testosterone products that have been on the market for decades ^{[3] [6]}. The reasonable, non-hyped position: if preserving fertility is a real priority and a man is a candidate for it (secondary hypogonadism, not primary testicular failure), enclomiphene addresses a real problem TRT creates. It's not a fertility booster in the sense of raising sperm counts above a normal baseline or guaranteeing conception. It maintains the status quo where TRT would erode it.

Can women take enclomiphene for fertility, and is that the same thing?

No, and this is worth being direct about because search traffic on "enclomiphene and pregnancy" sometimes comes from people expecting a female fertility answer. Enclomiphene is not prescribed to women for fertility treatment. Clomiphene citrate (the enclomiphene/zuclomiphene mixture) is the drug with a long history of use in female ovulation induction, and it is FDA-approved for that indication . Isolated enclomiphene has not been developed or approved for that use, and there's no meaningful clinical dataset on isolated enclomiphene in women trying to conceive. If the actual question is about a male partner's fertility while a couple is trying to conceive, that's the male-hypogonadism-and-SERM discussion covered throughout this article. If the question is about a female partner's fertility treatment, that's a separate drug (clomiphene, or other ART protocols) and a different conversation with a reproductive endocrinologist, not something enclomiphene is positioned to solve.

What should a man tell his doctor before starting enclomiphene if he's trying to conceive?

Bring the actual goal into the conversation explicitly: "I want higher testosterone but I don't want to compromise sperm production because we're trying to conceive." That single sentence changes what a knowledgeable prescriber will offer, because it rules out standard TRT as a first-line option and puts SERMs (enclomiphene or clomiphene) or hCG-based protocols on the table instead. Worth confirming before starting: a baseline semen analysis (so there's something to compare against later), baseline LH, FSH, and total/free testosterone, and a clear plan for follow-up testing at the 3-month mark given the spermatogenesis timeline discussed above ^[1]. A man with primary testicular failure (primary hypogonadism, where the testes themselves can't respond regardless of LH/FSH signal) is not a good candidate for enclomiphene since there's nothing left in the testes to stimulate. That distinction, primary versus secondary hypogonadism, is one a doctor needs to confirm with labs, not guess at. Because enclomiphene is compounded rather than FDA-approved, it also matters which pharmacy is filling it. Formulation consistency and dosing accuracy vary by compounder, which is part of why working through a provider-reviewed process, rather than an unregulated online source, matters more here than it would with an approved generic. Enclomiphene Direct connects patients with licensed prescribers who review labs and history first, and fulfillment runs through a licensed U.S. compounding pharmacy partner rather than the site itself compounding or shipping anything directly.

What are the real risks and unknowns with enclomiphene, honestly stated?

The biggest unknown isn't a scary side effect, it's the absence of long-term outcome data. No FDA approval means no required Phase 4 post-market surveillance, no standardized label with agency-vetted dosing, and no large multi-year safety dataset comparable to what exists for approved TRT formulations ^[3]. Known or reported issues from the trials that do exist: mood changes, headache, and rare visual disturbances associated with the clomiphene drug class more broadly ^[6]. Because enclomiphene is the isomer thought to carry less of the estrogen-agonist activity than zuclomiphene, some clinicians believe it may carry a lower side-effect burden than clomiphene itself, but that's a mechanistic argument, not something proven in a large head-to-head trial ^[5]. On the fertility side specifically, the honest summary is: enclomiphene preserves the hormonal signal that drives sperm production, and the available (smaller) trials back that up. It does not have trial evidence showing it increases pregnancy rates, and nobody should be sold that promise. For a full weighing of these tradeoffs against cost and convenience, enclomiphene pros and cons and the patient-reported outcomes in enclomiphene reviews are the next useful reads.

Frequently asked questions

Does enclomiphene help get a partner pregnant?

Not directly. Enclomiphene raises a man's testosterone while preserving the LH/FSH signal that drives sperm production, which TRT suppresses. That can keep his fertility intact during treatment, but no trial shows enclomiphene increases pregnancy rates in a partner. It maintains fertility potential; it doesn't boost it above normal or guarantee conception.

Can women take enclomiphene while trying to conceive?

No. Enclomiphene isn't prescribed to women and has no approved female fertility indication. Clomiphene citrate, which contains enclomiphene plus zuclomiphene, is the FDA-approved drug used for female ovulation induction. If a female partner needs fertility treatment, that's a separate conversation with a reproductive endocrinologist.

Is enclomiphene FDA-approved?

No. Enclomiphene (developed as Androxal) went through Phase 3 trials but was never approved by the FDA, and its developer, Repros Therapeutics, discontinued the program. What's sold today is compounded by pharmacies under prescription, not an FDA-approved manufactured drug.

How is enclomiphene different from clomiphene?

Clomiphene citrate is a mixture of two isomers: enclomiphene (trans) and zuclomiphene (cis). Enclomiphene does most of the anti-estrogenic work that raises LH, FSH, and testosterone. Zuclomiphene has a longer half-life and more estrogen-agonist activity, and is thought to contribute more side effects without much added benefit.

Does enclomiphene shrink the testicles like TRT does?

Generally not. TRT often shrinks testicles because external testosterone suppresses the LH/FSH signal that keeps them active. Enclomiphene increases that signal instead, so trial data and clinical reports generally show testicular size holding steady, though no large long-term study has measured this as a primary outcome.

How long does it take for sperm production to change after starting enclomiphene?

A full spermatogenic cycle takes about 64 to 74 days, plus roughly two more weeks for transit through the epididymis. Expect at least 3 months before a semen analysis reflects any real change, whether you're starting enclomiphene, stopping TRT, or switching between them.

Can enclomiphene reverse infertility caused by TRT?

It can help restart the LH/FSH signal that TRT suppressed, which is why it's sometimes used in post-TRT recovery protocols alongside or instead of hCG. Recovery time varies widely by individual and by how long TRT was used; some men recover in months, others take over a year.

Is enclomiphene safe to use long-term while trying to conceive?

There's no large, long-term safety dataset because enclomiphene was never FDA-approved as a standalone drug. Shorter trials show it preserves testosterone-driven fertility markers reasonably well, but ongoing lab monitoring (testosterone, LH, FSH, semen analysis) is the responsible way to use it long-term, not a set-and-forget approach.

What's the difference between enclomiphene and TRT for fertility?

TRT adds testosterone from outside, which suppresses the LH/FSH signal and often shuts down sperm production. Enclomiphene raises testosterone by stimulating the testes through that same signal, generally preserving sperm production and testicular size. Same testosterone goal, opposite effect on fertility.

Do I need a baseline semen analysis before starting enclomiphene?

It's a reasonable step if fertility preservation is the goal, since it gives you something concrete to compare against 3 months later. Baseline LH, FSH, and testosterone labs matter too, and they help confirm you have secondary (not primary) hypogonadism, which is what makes enclomiphene a rational option in the first place.

Where does enclomiphene actually come from if it's not FDA-approved?

It's compounded by licensed pharmacies under a doctor's prescription, following FDA rules for compounded medications (sections 503A/503B of the FD&C Act) rather than the standard new-drug approval pathway. Formulation and quality can vary by compounder, so the sourcing pharmacy matters.

Does enclomiphene work the same for primary and secondary hypogonadism?

No. Enclomiphene stimulates the pituitary-testes signaling axis, so it only works when the testes are capable of responding, which is the case in secondary hypogonadism. In primary hypogonadism, the testes themselves are the problem, and enclomiphene has nothing to stimulate.

Sources

1. Endocrine Society, Testosterone Therapy in Men with Hypogonadism: Clinical Practice Guideline: LH and FSH regulate Leydig and Sertoli cell function driving testosterone production and spermatogenesis
2. Kim et al., Journal of Sexual Medicine, enclomiphene vs. testosterone effects on gonadotropins: Enclomiphene increased testosterone, LH, and FSH while preserving sperm-relevant hormone levels compared to exogenous testosterone
3. FDA, Repros Therapeutics Androxal (enclomiphene citrate) regulatory history: Enclomiphene citrate (Androxal) completed Phase 3 trials but was never granted FDA approval
4. FDA, Human Drug Compounding overview of Sections 503A and 503B of the FD&C Act: Compounded drugs are regulated under separate FD&C Act provisions rather than the standard new-drug approval pathway
5. Kelly & Bonner et al., pharmacology review of clomiphene isomers: Clomiphene citrate is a mixture of enclomiphene and zuclomiphene isomers with differing estrogenic activity and half-lives
6. Wiehle et al., Fertility and Sterility, randomized trial of enclomiphene vs. testosterone gel: Enclomiphene raised testosterone while preserving sperm count and LH/FSH compared to topical testosterone gel
7. FDA-approved labeling reference for clomiphene citrate (Clomid): Clomiphene citrate is FDA-approved for use in female ovulation induction